A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
for Germ Cell Tumor
3 locations incl. Charlotte
Sponsor: Wake Forest University Health Sciences
Sex: All·Age: 18 - 70
Code: NCT06866964·Phase 2·Recruiting·Listed Mar 2025